至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Cell-Cycle Control of Bivalent Epigenetic Domains Regulates the Exit from Pluripotency.

Stem Cell Reports. 2015; 
Singh Amar M,Sun Yuhua,Li Li,Zhang Wenjuan,Wu Tianming,Zhao Shaying,Qin Zhaohui,Dalton Ste
Products/Services Used Details Operation
CRISPR Bacteria & Yeast Engineering The target gRNA expression constructs were ordered as individual 455 bp gBlocks (Genscript), which has U6 promotor, target sequences, guide RNA scaffold, and terminal signal, cloned into pUC57 vector. Get A Quote

摘要

Here we show that bivalent domains and chromosome architecture for bivalent genes are dynamically regulated during the cell cycle in human pluripotent cells. Central to this is the transient increase in H3K4-trimethylation at developmental genes during G1, thereby creating a "window of opportunity" for cell-fate specification. This mechanism is controlled by CDK2-dependent phosphorylation of the MLL2 (KMT2B) histone methyl-transferase, which facilitates its recruitment to developmental genes in G1. MLL2 binding is required for changes in chromosome architecture around developmental genes and establishes promoter-enhancer looping interactions in a cell-cycle-dependent manner. These cell-cycle-regulated loops... More

关键词